Skip Navigation



Hum. Reprod. Advance Access published online on September 22, 2006
Human Reproduction, doi:10.1093/humrep/del254
This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
21/11/2845    most recent
del254v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Barad, D.
Right arrow Articles by Gleicher, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barad, D.
Right arrow Articles by Gleicher, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received April 3, 2006
Revised May 22, 2006
Accepted May 27, 2006

Article

Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF

David Barad 1 * and Norbert Gleicher 2

1 Center for Human Reproduction, New York, NY; The Foundation for Reproductive Medicine, Chicago, IL; Department of Epidemiology and Social Medicine and Department of Obstetrics and Gynecology and Women’s Health, Albert Einstein College of Medicine, Bronx, NY
2 Center for Human Reproduction, New York, NY; The Foundation for Reproductive Medicine, Chicago, IL; Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, CT, USA

* To whom correspondence should be addressed.
David Barad, E-mail: dbarad{at}optonline.net


  Abstract

BACKGROUND: The aim of this study was to investigate the effect of treatment with dehydroepiandrosterone (DHEA) on fertility outcomes among women with diminished ovarian reserve. MATERIALS AND METHODS: This is a case-control study in an academically affiliated private infertility centre. Twenty-five women with significantly diminished ovarian reserve had one IVF cycle before and after DHEA treatment, with otherwise identical hormonal stimulation. Women received 75 mg of DHEA daily (25 mg three times daily) for an average of 17.6 ± 2.13 weeks. We performed a comparison of IVF outcome parameters, before and after DHEA treatment, including peak estradiol (E2) levels, oocyte and embryo numbers, oocyte and embryo quality and embryo transfer statistics. RESULTS: Paired analysis of IVF cycle outcomes in 25 patients, who underwent cycles both before and after DHEA supplementation, demonstrated significant increases in fertilized oocytes (P < 0.001), normal day 3 embryos (P = 0.001), embryos transferred (P = 0.005) and average embryo scores per oocyte (P < 0.001) after DHEA treatment. CONCLUSION: This study confirms the previously reported beneficial effects of DHEA supplementation on ovarian function in women with diminished ovarian reserve.

Keywords: dehydroepiandrosterone/embryo score/IVF/ovarian reserve/polycystic ovary syndrome.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
J. Balasch, F. Fabregues, F. Carmona, R. Casamitjana, and M. Tena-Sempere
Ovarian Luteinizing Hormone Priming Preceding Follicle-Stimulating Hormone Stimulation: Clinical and Endocrine Effects in Women with Long-Term Hypogonadotropic Hypogonadism
J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2367 - 2373.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
N. Gleicher, A. Weghofer, K. Oktay, and D. H. Barad
Can the FMR1 (Fragile X) Gene Serve As Predictor of Response to Ovarian Stimulation?
Reproductive Sciences, May 1, 2009; 16(5): 462 - 467.
[Abstract] [PDF]

Home page
 Hum ReprodHome page
F. Fabregues, J. Penarrubia, M. Creus, D. Manau, G. Casals, F. Carmona, and J. Balasch
Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial
Hum. Reprod., February 1, 2009; 24(2): 349 - 359.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
N. Gleicher and D. H. Barad
Androgen priming before ovarian stimulation for IVF
Hum. Reprod., December 1, 2008; 23(12): 2868 - 2870.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
K. Lossl, C. Yding Andersen, A. Loft, and A. Nyboe Andersen
Reply: Androgen priming before ovarian stimulation for IVF
Hum. Reprod., December 1, 2008; 23(12): 2870 - 2871.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
K. Lossl, C. Y. Andersen, A. Loft, N.L.C. Freiesleben, S. Bangsboll, and A. N. Andersen
Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial
Hum. Reprod., August 1, 2008; 23(8): 1820 - 1829.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. T. Page, A. M. Matsumoto, W. J. Bremner, M. Yasuda, S. Horie, T. T. Perls, N. Gleicher, D. Barad, K. S. Nair, and G. Smith
DHEA and Testosterone in the Elderly
N. Engl. J. Med., February 8, 2007; 356(6): 635 - 637.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.